Dear Doctor - Participate in the Survey on thromboprophylaxis " A recent survey of patients with thrombophilia found that most patients are not receiving adequate thromboprophylaxis. Thrombophilia is a condition that predisposes patients to developing blood clots, and thromboprophylaxis is the use of medication or other interventions to prevent blood clots from forming.The survey found that only 43% of patients with thrombophilia were receiving anticoagulant medication, which is the most effective form of thromboprophylaxis. This means that the majority of patients with thrombophilia are not being adequately protected from developing blood clots.There are several reasons why patients with thrombophilia may not be receiving appropriate thromboprophylaxis. First, many patients are not aware that they have thrombophilia. Second, even when patients are aware of their condition, they may not be aware of the importance of using anticoagulants or other forms of thromboprophylaxis. Third, some patients may be reluctant to take anticoagulants because of the potential side effects. Finally, some physicians may not be familiar with the latest guidelines for managing thrombophilia and therefore may not be prescribing anticoagulants to their patients with this condition.The results of this survey underscore the need for better education for both patients and physicians about thrombophilia . Participate in Surveys "
1.
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC
2.
Transplantation Fails to Improve Survival in Mantle Cell Lymphoma
3.
In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.
4.
PSMA PET Beats MRI in Prostate Cancer Staging Study
5.
Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor
1.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
2.
Multiple Primary Lung Cancer: Multidisciplinary Advances in Diagnosis and Care
3.
Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment
4.
Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy
5.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Navigating the Complexities of Ph Negative ALL - Part VIII
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
5.
Efficient Management of First line ALK-rearranged NSCLC - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation